ELVN (Enliven Therapeutics, Inc.) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold ELVN (Enliven Therapeutics, Inc.) with a combined value of $105.20M across 6,831,377 shares. The largest holder is BlackRock, Inc. with a position worth $55.65M (0.00% of their portfolio). 4 funds increased their holdings.
Total Institutional Value
$105.20M
Total Shares Held
6,831,377
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $55.65M | 0.00% | +2.7% |
| 2 | Point72 Asset Management, L.P. | $23.17M | 0.03% | +44.6% |
| 3 | CITADEL ADVISORS LLC | $22.21M | 0.00% | +24.3% |
| 4 | BAKER BROS. ADVISORS LP | $4.18M | 0.02% | +136.3% |